Related Experiment Videos
Muscular degeneration in Duchenne's dystrophy may be caused by a mitochondrial defect
1Laboratoire de Physiologie, UER de Médecine, Nantes, France.
Abstract:
Duchenne's dystrophy (DMD), a recessive chromosome X-related disease, is the most common and severe form of myopathy. The different theories (vascular, neurogenic, membraneous, calcic and auto-immune) formulated to account for this disease have not been swept away by the discovery of the DMD gene and the deficient protein, dystrophin, since the exact cellular role played by the latter is still unknown. Our work on skeletal muscle has demonstrated a mitochondrial deficiency of the calcium-specific protein, calmitine, in degenerating muscle of myopathic persons and animals. Considering its great affinity for calcium, this protein specific to skeletal muscle could be essential to mitochondrial calcium regulation and thus to the functioning of the entire muscle cell. Its deficiency in Duchenne's and Becker type muscular dystrophy could be due to a mitochondrial genome alteration solely accountable for muscular degeneration. This hypothesis challenges the supposedly essential but still undefined role that researchers have attributed to dystrophin.
Insights
Mitochondrial deficiency of calmitine, a calcium-binding protein, is observed in Duchenne muscular dystrophy (DMD). This finding suggests a potential mitochondrial genome alteration as the cause of muscular degeneration, challenging dystrophin
Area of Science:
- Biochemistry
- Genetics
- Cell Biology
Background:
- Duchenne muscular dystrophy (DMD) is a severe X-linked myopathy with an unknown cellular role for the deficient dystrophin protein.
- Existing theories on DMD pathogenesis (vascular, neurogenic, membraneous, calcic, auto-immune) remain inconclusive.
Purpose of the Study:
- To investigate the role of mitochondrial calcium regulation in DMD pathogenesis.
- To explore the potential involvement of the calcium-binding protein calmitine in muscular degeneration.
Main Methods:
- Analysis of skeletal muscle tissue from individuals and animals with muscular dystrophy.
- Assessment of mitochondrial deficiency and calmitine levels.
Main Results:
- A deficiency in the mitochondrial calcium-specific protein, calmitine, was identified in degenerating muscle of myopathic subjects.
- Calmitine's high affinity for calcium suggests its crucial role in mitochondrial calcium regulation and overall muscle cell function.
Conclusions:
- Calmitine deficiency in Duchenne and Becker muscular dystrophy may stem from a mitochondrial genome alteration.
- This hypothesis posits mitochondrial dysfunction as the primary cause of muscular degeneration, questioning the established role of dystrophin.